168 related articles for article (PubMed ID: 27846727)
21. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
22. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis.
Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Gosnell JE; Shen WT; Duh QY; Allen IE; Vriens MR; de Keizer B; Pampaloni MH; Suh I
Langenbecks Arch Surg; 2016 Nov; 401(7):925-935. PubMed ID: 27086309
[TBL] [Abstract][Full Text] [Related]
23. Current Methods of microRNA Analysis.
Bartošík M; Jiráková L
Klin Onkol; 2018; 31(Suppl 2):93-101. PubMed ID: 31023031
[TBL] [Abstract][Full Text] [Related]
24. [Fluorine-18 in radiopharmacy].
de Beco V; Le Bars D; Scherrmann JM
Ann Pharm Fr; 2008 Jan; 66(1):60-5. PubMed ID: 18435989
[TBL] [Abstract][Full Text] [Related]
25. [L-[methyl-(11C)]-methionine of high enantiomeric purity production via on-line 11C-methylation of L-homocysteine thiolactone hydrochloride].
Gomzina NA; Kuznetsova OF
Bioorg Khim; 2011; 37(2):216-22. PubMed ID: 21721254
[TBL] [Abstract][Full Text] [Related]
26. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H
Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107
[TBL] [Abstract][Full Text] [Related]
27. Nucleoside-based probes for imaging tumor proliferation using positron emission tomography.
Alauddin MM
J Labelled Comp Radiopharm; 2013; 56(3-4):237-43. PubMed ID: 24285330
[TBL] [Abstract][Full Text] [Related]
28. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
Dollé F
J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 11C-methionine PET and 18F-fluorodeoxyglucose PET in differentiated thyroid cancer.
Phan HT; Jager PL; Plukker JT; Wolffenbuttel BH; Dierckx RA; Links TP
Nucl Med Commun; 2008 Aug; 29(8):711-6. PubMed ID: 18753824
[TBL] [Abstract][Full Text] [Related]
30. Stability of 11C-labeled PET radiopharmaceuticals.
Fukumura T; Nakao R; Yamaguchi M; Suzuki K
Appl Radiat Isot; 2004 Dec; 61(6):1279-87. PubMed ID: 15388122
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
Miller PW; Long NJ; Vilar R; Gee AD
Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
[TBL] [Abstract][Full Text] [Related]
33. Importance of Membrane Proteins in the Treatment of Tumor Diseases and the Possibilities of Their Further Study.
Dosedělová L; Nekulová M; Zahradníková M; Faktor J; Vojtěšek B; Hernychová L
Klin Onkol; 2018; 31(Suppl 2):32-40. PubMed ID: 31023022
[TBL] [Abstract][Full Text] [Related]
34. Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG.
Zhao C; Chen Z; Ye X; Zhang Y; Zhan H; Aburano T; Tian M; Zhang H
Nucl Med Commun; 2009 Dec; 30(12):971-7. PubMed ID: 19696689
[TBL] [Abstract][Full Text] [Related]
35. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
[TBL] [Abstract][Full Text] [Related]
36. [Current trends in using PET radiopharmaceuticals for diagnostics in oncology].
Adam J; Kadeřávek J; Kužel F; Vašina J; Rehák Z
Klin Onkol; 2014; 27 Suppl 1():S129-36. PubMed ID: 24945550
[TBL] [Abstract][Full Text] [Related]
37. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
38. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
Yamada Y; Uchida Y; Tatsumi K; Yamaguchi T; Kimura H; Kitahara H; Kuriyama T
J Nucl Med; 1998 Jul; 39(7):1160-6. PubMed ID: 9669387
[TBL] [Abstract][Full Text] [Related]
39. Metabolic assessment of intracranial tuberculomas using 11C-methionine and 18F-FDG PET/CT.
D'Souza MM; Sharma R; Jaimini A; Panwar P; Bansal A; Tripathi M; Varshney R; Pandey S; Mondal A
Nucl Med Commun; 2012 Apr; 33(4):408-14. PubMed ID: 22301451
[TBL] [Abstract][Full Text] [Related]
40. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
